(39 days)
Not Found
No
The summary describes a quality control material for clinical chemistry assays and does not mention any AI or ML components.
No
This device is for in vitro diagnostic use, intended for quality control of assays to monitor precision and detect analytical deviations, not for therapeutic purposes.
No
Explanation: The device is described as a "control" used for "quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations." This indicates it's a quality control material rather than a diagnostic device that directly diagnoses a patient's condition.
No
The device description clearly states the device is a liquid control material supplied in vials, indicating it is a physical substance, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the controls are "intended for in vitro diagnostic use in the quality control of Ammonia and Alcohol Assays". This is the primary indicator of an IVD.
- Purpose: The purpose of the device is to "monitor precision and to detect systematic analytical deviations on clinical chemistry systems." This is a function performed in vitro (outside the body) to assess the performance of diagnostic tests.
- Device Description: The description details a liquid control material used in a laboratory setting, consistent with the nature of IVD controls.
- Intended User / Care Setting: The intended user is associated with "clinical chemistry systems," which are used for in vitro diagnostic testing.
The information provided clearly aligns with the definition and purpose of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Randox Ammonia Ethanol Control Levels 1, 2 & 3 are intended for in vitro diagnostic use in the quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations on clinical chemistry systems. This device is for prescription use only.
Product codes
JJY
Device Description
The Randox Ammonia Ethanol Controls are liquid and supplied at levels 1, 2 and level 3. The base matrix used for the manufacture of Randox Ammonia Ethanol Controls Levels 1, 2 & 3 is saturated benzoic acid with added chemicals.
Each level of control is supplied in liquid form in 6 x 2ml vials and is ready for use. Only the required amount of product should be removed from the vial. After use, any residual product should not be returned to the original vial.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Open vial stability of the Randox Ammonia Ethanol Control Levels 1, 2 & 3 was assessed by opening a set of Randox Ammonia Ethanol Control levels 1, 2 & 3 and handling them according to the package insert. Vials were stored at +2 to +8°C for 7, 14, 21 and 30 days and tested on the ADVIA 1650 for Ammonia and RX Daytona for Ethanol.
The acceptance criteria state the percentage deviation of open vial material to fresh material should be
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
510 (k) Summary
1. SAFETY AND EFFECTIVENESS AS REQUIRED BY 21 CFR 807.92 STATEMENT
This summary of the 510(k) safety and effectiveness information is being submitted in accordance with the requirement 21 CFR 807.92.
2. SUBMITTER NAME AND ADDRESS
Name: Dr Pauline Armstrong
Address: Randox Laboratories Limited 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom.
Telephone: +44 (0) 28 9442 2413 Fax: +44 (0) 28 9445 2912 E-mail: Pauline.Armstrong@randox.com
Date of Summary Preparation: March 19, 2014
3. 510k NUMBER. DEVICE PROPRIETARY NAME, COMMON NAME, PURPOSE FOR SUBMISSION, REGULATORY CLASSIFCATION, PANEL, PRODUCT CODE AND 21 CFR NUMBER
510k No: K140393
Device Proprietary Name: Randox Ammonia Ethanol Control Levels 1. 2 & 3
Common Name: Randox Ammonia Ethanol Control Levels 1, 2 & 3
Purpose for Submission: New Device
Requiatory Classification: Multi-analyte Controls, All kinds (Assayed and Unassayed)
Panel: Clinical Chemistry
Product Code: JJY
21 CFR Number: 21 CFR 862.1660
1
1
4. PREDICATE DEVICE PROPRIETARY NAMES AND 510 (k) NUMBERS
Predicate Device Proprietary Name: Liquichek Ethanol/ Ammonia Control
510 (k) Number: K123198
5. INTENDED USE
The Randox Ammonia Ethanol Control Levels 1, 2 & 3 are intended for in vitro diagnostic use in the quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations on clinical chemistry systems. This device is for prescription use only
6. DEVICE DESCRIPTION
The Randox Ammonia Ethanol Controls are liquid and supplied at levels 1, 2 and level 3. The base matrix used for the manufacture of Randox Ammonia Ethanol Controls Levels 1, 2 & 3 is saturated benzoic acid with added chemicals.
Each level of control is supplied in liquid form in 6 x 2ml vials and is ready for use. Only the required amount of product should be removed from the vial. After use, any residual product should not be returned to the original vial.
2
7. PREDICATE DEVICE COMPARISON TABLE
1 ﺪﻳﻨ
ﻠﻘﺎ :
ﻟﻘﺎﻧ !
な 发
COMPARISON OF RANDOX AMMONIA ETHANOL CONTROL LEVELS 1, 2 AND 3 WITH THE PREDICATE DEVICE
| CHARACTERISTICS | RANDOX ETHANOL CONTROL
LEVELS 1, 2 AND 3
(New Device) | BIO-RAD LABORATORIES
LIQUICHEK
ETHANOL/AMMONIA CONTROL
K123198
(Predicate Device) |
|-----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| SIMILARITIES | | |
| INTENDED USE | The Randox Ammonia Ethanol Control
Levels 1, 2 & 3 are intended for in vitro
diagnostic use in the quality control of
Ammonia and Alcohol Assays to monitor
precision and to detect systematic
analytical deviations on clinical chemistry
systems. This device is for prescription
use only. | Liqichek Ethanol/Ammonia Control is
intended for use as an assayed quality
control serum to monitor the precision of
laboratory testing procedures for
Ammonia and Alcohol assays. |
| FORMAT | Liquid | Liquid |
| STORAGE
(Unopened) | 2 to 8 °C
Until expiration date | 2 to 8 °C
Until expiration date |
| DIFFERENCES | | |
| MATRIX | Saturated Benzoic acid with added
chemicals. | Bovine serum albumin with added
chemicals, stabilisers and preservatives. |
| OPEN VIAL CLAIM | 30 days at +2 to 8°C. | 20 days at +2 to 8°C on board Siemens
Dimension Vista instrument. |
| SIZE | 2ml | 2.5ml |
| SHELF LIFE | 18 months | 24 months |
3
3
8. SUMMARY OF STABILITY STUDIES
Open vial stabiltiy
r T
Open vial stability of the Randox Ammonia Ethanol Control Levels 1, 2 & 3 was assessed by opening a set of Randox Ammonia Ethanol Control levels 1, 2 & 3 and handling them according to the package insert. Vials were stored at +2 to +8°C for 7, 14, 21 and 30 days and tested on the ADVIA 1650 for Ammonia and RX Daytona for Ethanol.
The acceptance criteria state the percentage deviation of open vial material to fresh material should be ≤5%.
The table below shows the summary of the open vial stability at Day 30.
Results
Open Vial Stability Day 30
| Ammonia Analyte on
the ADVIA 1650 | Open Vial
Result (umol/l) | Fresh Result
(umol/l) | % Difference |
|--------------------------------------|------------------------------|--------------------------|--------------|
| Level 1 | 55.19 | 54.79 | 0.7% |
| Level 2 | 151.24 | 152.60 | -0.9% |
| Level 3 | 284.35 | 290.27 | -2.0% |
| Ethanol Analyte on
the RX Daytona | Open Vial
Result (mg/dl) | Fresh Result
(mg/dl) | % Difference |
|--------------------------------------|-----------------------------|-------------------------|--------------|
| Level 1 | 51.83 | 49.50 | 4.7% |
| Level 2 | 165.04 | 163.16 | 1.2% |
| Level 3 | 292.18 | 387.22 | 1.3% |
The data demonstrates that the Randox Ammonia Ethanol Control levels 1, 2 & 3 are stable for 30 days at + 2 to 8°C.
4
Real Time Testing
The Randox Ammonia Ethanol Control levels 1, 2 & 3 were stored at ultra frozen conditions -75 to -90°C. Following storage at the ultra frozen temperature, the controls were then tested and on the ADVIA 1650 for Ammonia and RX Davtona for Ethanol alongside control material stored unopened at the routine storage temperature of +2 to +8°C at various timepoints and the percentage deviation is calculated.
The acceptance criteria state the percentage deviation to controls stored at the routine temperature should be ≤5%.
Current Real Time studies support a 18 month shelf life.
9. SUMMARY OF VALUE ASSIGNMENT
Value assignment is used to calculate an assigned value for the Randox Ammonia Ethanol Control Levels 1, 2 & 3. The value assignment process for the Randox Ammonia Ethanol controls is based on the master lot concept. The value is assigned by performing nested testing of the new lot of control against the master lot on a clinical chemistry analyser (ADVIA 1650 for Ammonia. RXDaytona for Ethanol). Multiple replicates of the test calibrator and controls are assessed on the clinical chemistry analyser and the mean and CV calculated. The recovery of the master lot is also measured.
The acceptance criteria states the precision measured by the CV should be less than or equal to 10% for Control Level 1 and less than or equal to 7.5% for Control Levels 2 and Level 3. The recovery error of the master lot is also measured and should be ≤ 7.5% for all control levels. An assigned value is calculated and a +/-20% range applied.
Control ranges stated in the package insert are summarized in the tables below.
| LEVEL I | ||||
|---|---|---|---|---|
| ANALYTE | SYSTEM | METHOD | TARGET | RANGE |
| AMMONIA (μmol/l) | ADVIA 1650 | Enzymatic (UV) | 55 | 44 - 66 |
| ETHANOL (g/l) | RX Daytona | Enzymatic (UV) | 0.51 | 0.41 - 0.61 |
| ETHANOL (mg/dl) | RX Daytona | Enzymatic (UV) | 51 | 41 - 61 |
| LEVEL 2 | ||||
|---|---|---|---|---|
| ANALYTE | SYSTEM | METHOD | TARGET | RANGE |
| AMMONIA (µmol/l) | ADVIA 1650 | Enzymatic (UV) | 141 | 113 - 169 |
5
| ETHANOL (g/l) | RX Daytona | Enzymatic (UV) | 1.47 | 1.18 - 1.76 |
|---|---|---|---|---|
| ETHANOL (mg/dl) | RX Daytona | Enzymatic (UV) | 147 | 118 - 176 |
| LEVEL 3 | ||||
|---|---|---|---|---|
| ANALYTE | SYSTEM | METHOD | TARGET | RANGE |
| AMMONIA (µmol/l) | ADVIA 1650 | Enzymatic (UV) | 297 | 238 - 356 |
| ETHANOL (g/l) | RX Daytona | Enzymatic (UV) | 3.76 | 3.01 - 4.51 |
| ETHANOL (mg/dl) | RX Daytona | Enzymatic (UV) | 376 | 301 - 451 |
10. CONCLUSION
ជំ ?" ﺃﺷﺨﺎﺹ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ 产
1
Testing results indicate that the proposed device is substantially equivalent to the predicate device.
6
Image /page/6/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion around the symbol. The logo is black and white.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 25, 2014
RANDOX LABORATORIES LIMITED PAULINE ARMSTRONG 55 DIAMOND RD. CRUMLIN, CO. ANTRIM BT29 4QY UK
Re: K140393
Trade/Device Name: Randox Ammonia Ethanol Control Levels 1, 2 and Level 3 Regulation Number: 21 CFR 862.1660 Regulation Name: Quality control material (assayed and unassayed) Regulatory Class: 1, Reserved Product Code: JJY Dated: February 11, 2014 Received: February 21, 2014
Dear Dr. Armstrong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Parts 801 and 809): medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
7
Page 2-Dr. Armstrong
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809). please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resources/orYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Courtney H. Lias -S
Courtney H. Lias. Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
8
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) k 140393
Device Name
Randox Ammonia Ethanol Controls Levels 1, 2, & 3
Indications for Use (Describe)
The Randox Ammonia Ethanol Controls Levels 1, 2, & 3 are intended for in vitro diagnostic use in the quality control of Ammonia and Alcohol Assays to monitor precision and to detect systematic analytical deviations on clinical chemistry systems. This device is for prescription use only.
Type of Use (Select one or both, as applicable)
2 Prescription Use (Part 21 CFR 801 Subpart D)
L Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Yung W. Chan -S
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.